• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Opera Limited

    12/3/24 4:30:09 PM ET
    $OPRA
    Computer Software: Prepackaged Software
    Technology
    Get the next $OPRA alert in real time by email
    6-K 1 opra_6-k_2024-agm-result.htm 6-K 6-K

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER

    PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

    THE SECURITIES EXCHANGE ACT OF 1934

    For the month of December 2024

    Commission File Number: 001-38588

     

    OPERA LIMITED

     

    Vitaminveien 4,

    0485 Oslo, Norway

    (Address of principal executive office)

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

    Form 20-F ☒ Form 40-F ☐


    Voting Results of the 2024 Annual General Meeting of the Company

     

    Change of Authorized Share Capital and Share Consolidation

     

    IT WAS RESOLVED BY AN ORDINARY RESOLUTION THAT every two (2) issued and unissued ordinary shares of a nominal or par value of US$0.0001 each in the capital of the Company be consolidated into one (1) share of a nominal or par value of US$0.0002 each (each a “Consolidated Share”), and such Consolidated Shares shall rank pari passu in all respects with each other in accordance with the Company's currently effective memorandum and articles of association (the “Share Consolidation”) such that following the Share Consolidation the authorized share capital of the Company will be changed (the “Change of Authorized Share Capital”) from US$50,000 divided into 500,000,000 shares of a nominal or par value of US$0.0001 each, to US$50,000 divided into 250,000,000 shares of a nominal or par value of US$0.0002 each, and no fractional shares be issued in connection with the Share Consolidation.

     

    Voting Results of the 2024 Annual General Meeting

     

    A total of 137,767,764 ordinary shares (including ordinary shares represented by ADSs), representing 77.9% of all issued and outstanding shares of the Company as of the record date, were present at the meeting in person or by proxy. The voting results are as follows:

     

     

     

    For

     

     

    Against

     

     

    Abstain

     

    Resolutions

     

    Votes

     

     

    %

     

     

    Votes

     

     

    %

     

     

    Votes

     

     

    %

     

    Change of Authorized Share Capital and Share Consolidation

     

     

    137,344,082

     

     

     

    99.7

    %

     

     

    253,334

     

     

     

    0.2

    %

     

     

    170,348

     

     

     

    0.1

    %

     

    The Share Consolidation will become effective on December 6, 2024. Concurrently on the same day, a change in the ADS ratio proportionate to the Share Consolidation will take effect.


    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

    Opera Limited

    Date: December 3, 2024

    By:

    /s/ James Yahui Zhou

    Name:

    James Yahui Zhou

    Title:

    Chairman of the Board and Chief Executive Officer

     


    Get the next $OPRA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $OPRA

    DatePrice TargetRatingAnalyst
    2/5/2025$25.00Overweight
    Piper Sandler
    12/14/2023$20.00Buy
    B. Riley Securities
    12/13/2023$16.50Buy
    Goldman
    More analyst ratings